Courses & Units
Therapeutics in Practice (4) CSA406
Introduction
Therapeutics in Practice 4 is designed to further develop the student’s ability to determine the most appropriate pharmacotherapeutic management for a range of medical conditions. Drug therapy is the cornerstone for the management of most if not all common medical conditions. The unit builds on the student’s understanding of pharmacology, human biology and basic therapeutics. Having covered a range of conditions in CSA322 and CSA306, students will address other common conditions (such as malignant disease) as well as look at overarching themes, such as geriatrics, paediatrics and gender-specific health issues. The knowledge gained in this unit will be fundamental to the hospital visits in this unit and to hospital and community placements undertaken during the year. Therapeutics in Practice 4 will also form an important basis for further studies relating to Medication Reviews undertaken in Pharmacy Practice CSA457 and CSA430.
Summary
| Unit name | Therapeutics in Practice (4) |
|---|---|
| Unit code | CSA406 |
| Credit points | 12.5 |
| College/School | College of Health and Medicine School of Pharmacy and Pharmacology |
| Discipline | Pharmacy |
| Coordinator | Mrs Kendall Stephens |
| Delivered By | University of Tasmania |
| Level | Advanced |
Availability
| Location | Study period | Attendance options | Available to | ||
|---|---|---|---|---|---|
| Hobart | Semester 1 | On-Campus | International | Domestic | |
Key
- On-campus
- Off-Campus
- International students
- Domestic students
Note
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
Key Dates
| Study Period | Start date | Census date | WW date | End date |
|---|---|---|---|---|
| Semester 1 | 26/2/2024 | 22/3/2024 | 15/4/2024 | 2/6/2024 |
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2024 are indicative and subject to change. Finalised census dates for 2024 will be available from the 1st October 2023. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
Learning Outcomes
- Identify, prioritise and resolve medication-related problems.
- Design approaches to the management of disease and illness by applying pathophysiology, epidemiology, and pharmacotherapeutic knowledge.
- Devise patient-centred therapeutic plans by utilising medical evidence, guidelines, drug references, and national health policies.
- Communicate medication-related problems and pharmacotherapeutic recommendations.
Fee Information
| Field of Education | Commencing Student Contribution 1,3 | Grandfathered Student Contribution 1,3 | Approved Pathway Course Student Contribution 2,3 | Domestic Full Fee 4 |
|---|---|---|---|---|
| 019907 | $1,118.00 | $1,118.00 | not applicable | $2,596.00 |
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
Requisites
Prerequisites
all yr-3 BPharm unitsTeaching
| Teaching Pattern | 3hr Independent learning weekly 1hr online seminar weekly 2hr on campus workshop weekly 3hr clinical rounds fortnightly 20min on campus mid semester test - week 7 only |
|---|---|
| Assessment | Medication review and management plan (10%)|Mid-semester oral examination (15%)|End of Semester Written examination (35%)|End of Semester Oral examination (40%) |
| Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
| Required |
Required readings will be listed in the unit outline prior to the start of classes. |
|---|---|
| Recommended | It is recommended that you have the following textbook: DiPiro et al. Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical (12th Edition, ISBN 978-1-264-26454-4) In addition to the recommended textbook, students will be guided to a variety of other reading material relevant to the area of study. Links will be provided to these materials through MyLO where possible. The majority of these materials will be available online, either freely accessible or through the University Library. Students will also find the following resources (e-versions are available to pharmacy students via EPOCH) highly valuable for CSA406 and other units (e.g., CSA457, CSA430): - UpToDate, Wolters Kluwer | Links | Booktopia textbook finder |
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.